TRACON Pharmaceutical (TCON)
1.79
-0.10 (5.29%)
Upcoming Events
Latest Headlines
Form S-1 Tracon Pharmaceuticals,
April 12, 2024 4:53 PM - SEC Filing
Form 8-K Tracon Pharmaceuticals, For: Apr 12
April 12, 2024 4:43 PM - SEC Filing
Form 424B5 Tracon Pharmaceuticals,
April 12, 2024 4:36 PM - SEC Filing
Form 8-K Tracon Pharmaceuticals, For: Apr 10
April 10, 2024 8:06 AM - SEC Filing
Form 8-K Tracon Pharmaceuticals, For: Apr 08
April 8, 2024 9:15 AM - SEC Filing
TRACON Pharmaceutical (TCON) Announces Reverse Stock Split
April 8, 2024 9:10 AM - StreetInsider
TRACON Pharmaceuticals Announces Reverse Stock Split
April 8, 2024 9:10 AM - Globe NewsWire
Form SC 13G/A Tracon Pharmaceuticals, Filed by: Ikarian Capital, LLC
April 5, 2024 4:11 PM - SEC Filing
Tracon Pharmaceuticals (TCON) PT Lowered to $3 at H.C. Wainwright on lower PoS for envafolimab
April 4, 2024 6:36 AM - StreetInsider
Form 8-K Tracon Pharmaceuticals, For: Apr 03
April 3, 2024 8:05 AM - SEC Filing
TRACON Pharmaceutical (TCON) Provides Update on Ongoing ENVASARC Phase 2 Trial
April 3, 2024 8:01 AM - StreetInsider
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
April 3, 2024 8:00 AM - Globe NewsWire
Form SC 13G/A Tracon Pharmaceuticals, Filed by: aaronson wayne
March 19, 2024 11:20 AM - SEC Filing
Form 4 Tracon Pharmaceuticals, For: Mar 12 Filed by: Brown Scott B.
March 13, 2024 6:00 PM - SEC Filing
Form 4 Tracon Pharmaceuticals, For: Mar 12 Filed by: THEUER CHARLES
March 13, 2024 5:56 PM - SEC Filing
Form S-8 Tracon Pharmaceuticals,
March 7, 2024 5:04 PM - SEC Filing
Form 10-K Tracon Pharmaceuticals, For: Dec 31
March 5, 2024 5:01 PM - SEC Filing
Form 8-K Tracon Pharmaceuticals, For: Mar 05
March 5, 2024 4:09 PM - SEC Filing
TRACON Pharmaceutical (TCON) Tops Q4 EPS by 7c
March 5, 2024 4:03 PM - StreetInsider
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
March 5, 2024 4:02 PM - Globe NewsWire
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
February 28, 2024 4:02 PM - Globe NewsWire
Form SC 13G/A Tracon Pharmaceuticals, Filed by: Lincoln Park Capital Fund, LLC
February 14, 2024 4:33 PM - SEC Filing
Form SC 13D/A Tracon Pharmaceuticals, Filed by: Opaleye Management Inc.
February 9, 2024 4:06 PM - SEC Filing
Full Article List
